Farther Finance Advisors LLC increased its position in Relx Plc (NYSE:RELX – Free Report) by 10.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,438 shares of the technology company’s stock after purchasing an additional 2,188 shares during the period. Farther Finance Advisors LLC’s holdings in Relx were worth $1,019,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. Raymond James Financial Inc. acquired a new position in Relx during the 4th quarter valued at about $44,516,000. FMR LLC boosted its position in shares of Relx by 8.3% during the third quarter. FMR LLC now owns 7,148,837 shares of the technology company’s stock valued at $339,284,000 after buying an additional 548,423 shares during the last quarter. Bank of Montreal Can grew its holdings in Relx by 194.9% during the third quarter. Bank of Montreal Can now owns 227,211 shares of the technology company’s stock worth $10,806,000 after buying an additional 150,163 shares in the last quarter. ABC Arbitrage SA bought a new stake in Relx during the fourth quarter worth $6,296,000. Finally, Public Employees Retirement System of Ohio purchased a new stake in Relx in the 3rd quarter valued at $6,366,000. Institutional investors and hedge funds own 15.02% of the company’s stock.
Relx Price Performance
Shares of NYSE:RELX opened at $48.99 on Friday. The firm has a market capitalization of $91.04 billion, a PE ratio of 26.34, a P/E/G ratio of 2.73 and a beta of 0.90. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The company has a 50-day moving average price of $48.86 and a two-hundred day moving average price of $47.59. Relx Plc has a twelve month low of $40.25 and a twelve month high of $51.99.
Relx Increases Dividend
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on the stock. Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday. StockNews.com downgraded shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Finally, Redburn Atlantic assumed coverage on shares of Relx in a research report on Wednesday, January 8th. They set a “buy” rating on the stock.
View Our Latest Stock Report on Relx
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Further Reading
- Five stocks we like better than Relx
- What does consumer price index measure?
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- The 3 Best Blue-Chip Stocks to Buy Now
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Roth IRA Calculator: Calculate Your Potential Returns
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.